Evaluation of clinical safety and effectiveness when placing regular-diameter implants in the molar area
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0008903
- Lead Sponsor
- Osstem Implant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
1. Patients who signed the clinical trial consent form
2. Adult patients over 20 years of age
3. Patients with sufficient bone height and appropriate bone width
4. Patients whose extraction site has been completely healed (patients with a healing period of at least 2 months after extraction)
5. Patients with 2 or more missing teeth in the upper or lower molar region
1. Patients whose predispositions that could intervene in clinical research results, such as periodontal disease and caries in the oral cavity, have not been completely removed before implant placement
2. Patients with Bruxism or Clenching Habit
3. Pregnant women and patients with uncontrolled systemic disease
4. Persons taking drugs for bone diseases such as osteoporosis
5. Patients with a history of radiation therapy to the face and neck
6. Mental illness or suspected mental illness
7. People who are hypersensitive to implant materials
8. Patients with a history of receiving chemotherapy such as chemotherapy for the past 1 year
9. Persons with a history of recent myocardial infarction or uncontrolled hemorrhagic disease
10. Others who are ethically or who may affect the results of a clinical trial and are inappropriate to participate in a clinical trial as determined by the clinical trial director
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of peri-implant marginal bone loss within the observation period
- Secondary Outcome Measures
Name Time Method implant success rate;periodontal index;Maintenance and management of prosthesis